Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
July-2021 Volume 22 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
July-2021 Volume 22 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

lncRNA WT1‑AS is upregulated in osteoporosis and regulates the apoptosis of osteoblasts by interacting with p53

  • Authors:
    • Chaoqun Wang
    • Quan Xie
    • Wen Sun
    • Ying Zhou
    • Yu Liu
  • View Affiliations / Copyright

    Affiliations: Department of Nuclear Medicine, Hainan General Hospital, Haikou, Hainan 570311, P.R. China, Department of Nuclear Medicine, The First Affiliated Hospital of Hainan Medical University, Haikou, Hainan 570100, P.R. China, Cancer Institute Of Hainan Medicail University, The First Affiliated Hospital of Hainan Medical University, Haikou, Hainan 570100, P.R. China
    Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 734
    |
    Published online on: May 9, 2021
       https://doi.org/10.3892/etm.2021.10166
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

In cervical cancer, cellular tumor antigen p53 (p53) interacts with long non‑coding WT1 antisense RNA (WT1‑AS) and this protein serves an important role in osteoporosis. The present study aimed to investigate the role of WT1‑AS in osteoporosis. WT1‑AS was upregulated in the plasma of patients with osteoporosis and was positively correlated with p53 expression. Altered expression of WT1‑AS and p53 separated patients with osteoporosis from healthy controls. Expression levels of WT1‑AS and p53 decreased with prolonged treatment. In osteoblasts, WT1‑AS overexpression resulted in increased p53 expression, while WT1‑AS small interfering RNA (siRNA) silencing resulted in decreased p53 expression. In addition, WT1‑AS overexpression resulted in increased apoptosis rate, while WT1‑AS siRNA silencing resulted in decreased apoptosis rate in osteoblasts. p53 overexpression attenuated the effects of WT1‑AS siRNA silencing on cell apoptosis. Therefore, WT1‑AS was upregulated during osteoporosis and regulated the apoptosis of osteoblasts by interacting with p53.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

View References

1 

Siris ES, Adler R, Bilezikian J, Bolognese M, Dawson-Hughes B, Favus MJ, Harris ST, Jan de Beur SM, Khosla S, Lane NE, et al: The clinical diagnosis of osteoporosis: A position statement from the National Bone Health Alliance Working Group. Osteoporos Int. 25:1439–1443. 2014.PubMed/NCBI View Article : Google Scholar

2 

Khosla S and Hofbauer LC: Osteoporosis treatment: Recent developments and ongoing challenges. Lancet Diabetes Endocrinol. 5:898–907. 2017.PubMed/NCBI View Article : Google Scholar

3 

Lötters FJB, van den Bergh JP, de Vries F and Rutten-van Mölken MP: Current and future incidence and costs of osteoporosis-related fractures in the Netherlands: Combining claims data with BMD measurements. Calcif Tissue Int. 98:235–243. 2016.PubMed/NCBI View Article : Google Scholar

4 

Curtis EM, Moon RJ, Dennison EM, Harvey NC and Cooper C: Recent advances in the pathogenesis and treatment of osteoporosis. Clin Med (Lond). 15 (Suppl 6):S92–S96. 2015.PubMed/NCBI View Article : Google Scholar

5 

Raisz LG: Pathogenesis of osteoporosis: Concepts, conflicts, and prospects. J Clin Invest. 115:3318–3325. 2005.PubMed/NCBI View Article : Google Scholar

6 

Reyes J, Chen JY, Stewart-Ornstein J, Karhohs KW, Mock CS and Lahav G: Fluctuations in p53 signaling allow escape from cell-cycle arrest. Mol Cell. 2018. 71:581–591. e5. 2018.PubMed/NCBI View Article : Google Scholar

7 

Willms A, Schittek H, Rahn S, Sosna J, Mert U, Adam D and Trauzold A: Impact of p53 status on TRAIL-mediated apoptotic and non-apoptotic signaling in cancer cells. PLoS One. 14(e0214847)2019.PubMed/NCBI View Article : Google Scholar

8 

Yeo CQX, Alexander I, Lin Z, Lim S, Aning OA, Kumar R, Sangthongpitag K, Pendharkar V, Ho VHB and Cheok CF: p53 maintains genomic stability by preventing interference between transcription and replication. Cell Rep. 15:132–146. 2016.PubMed/NCBI View Article : Google Scholar

9 

Hirasawa H, Tanaka S, Sakai A, Tsutsui M, Shimokawa H, Miyata H, Moriwaki S, Niida S, Ito M and Nakamura T: ApoE gene deficiency enhances the reduction of bone formation induced by a high-fat diet through the stimulation of p53-mediated apoptosis in osteoblastic cells. J Bone Miner Res. 22:1020–1030. 2007.PubMed/NCBI View Article : Google Scholar

10 

Weinstein RS and Manolagas SC: Apoptosis and osteoporosis. Am J Med. 108:153–164. 2000.PubMed/NCBI View Article : Google Scholar

11 

Zhen YF, Wang GD, Zhu LQ, Tan SP, Zhang FY, Zhou XZ and Wang XD: P53 dependent mitochondrial permeability transition pore opening is required for dexamethasone-induced death of osteoblasts. J Cell Physiol. 229:1475–1483. 2014.PubMed/NCBI View Article : Google Scholar

12 

Hao L, Fu J, Tian Y and Wu J: Systematic analysis of lncRNAs, miRNAs and mRNAs for the identification of biomarkers for osteoporosis in the mandible of ovariectomized mice. Int J Mol Med. 40:689–702. 2017.PubMed/NCBI View Article : Google Scholar

13 

Cui L, Nai M, Zhang K, Li L and Li R: lncRNA WT1-AS inhibits the aggressiveness of cervical cancer cell via regulating p53 expression via sponging miR-330-5p. Cancer Manag Res. 11:651–667. 2019.PubMed/NCBI View Article : Google Scholar

14 

Coulson KA, Reed G, Gilliam BE, Kremer JM and Pepmueller PH: Factors influencing fracture risk, T score, and management of osteoporosis in patients with rheumatoid arthritis in the Consortium of Rheumatology Researchers of North America (CORRONA) registry. J Clin Rheumatol. 15:155–160. 2009.PubMed/NCBI View Article : Google Scholar

15 

Al-Azzawi F: Prevention of postmenopausal osteoporosis and associated fractures: Clinical evaluation of the choice between estrogen and bisphosphonates. Gynecol Endocrinol. 24:601–609. 2008.PubMed/NCBI View Article : Google Scholar

16 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.PubMed/NCBI View Article : Google Scholar

17 

Du T, Zhang B, Zhang S, Jiang X, Zheng P, Li J, Yan M, Zhu Z and Liu B: Decreased expression of long non-coding RNA WT1-AS promotes cell proliferation and invasion in gastric cancer. Biochim Biophys Acta. 1862:12–19. 2016.PubMed/NCBI View Article : Google Scholar

18 

Dai SG, Guo LL, Xia X and Pan Y: Long non-coding RNA WT1-AS inhibits cell aggressiveness via miR-203a-5p/FOXN2 axis and is associated with prognosis in cervical cancer. Eur Rev Med Pharmacol Sci. 23:486–495. 2019.PubMed/NCBI View Article : Google Scholar

19 

Komori T: Cell death in chondrocytes, osteoblasts, and osteocytes. Int J Mol Sci. 17(2045)2016.PubMed/NCBI View Article : Google Scholar

20 

Lorentzon M and Cummings SR: Osteoporosis: The evolution of a diagnosis. J Intern Med. 277:650–661. 2015.PubMed/NCBI View Article : Google Scholar

21 

Thomson DW and Dinger ME: Endogenous microRNA sponges: Evidence and controversy. Nat Rev Genet. 17:272–283. 2016.PubMed/NCBI View Article : Google Scholar

22 

Yu Y, Newman H, Shen L, Sharma D, Hu G, Mirando AJ, Zhang H, Knudsen E, Zhang GF, Hilton MJ, et al: Glutamine metabolism regulates proliferation and lineage allocation in skeletal stem cells. Cell Metab. 29:966–978. e4. 2019.PubMed/NCBI View Article : Google Scholar

23 

Hayashi M, Nakashima T, Yoshimura N, Okamoto K, Tanaka S and Takayanagi H: Autoregulation of osteocyte Sema3A orchestrates estrogen action and counteracts bone aging. Cell Metab. 29:627–637.e5. 2019.PubMed/NCBI View Article : Google Scholar

24 

Fan Y, Hanai JI, Le PT, Bi R, Maridas D, DeMambro V, Figueroa CA, Kir S, Zhou X, Mannstadt M, et al: Parathyroid hormone directs bone marrow mesenchymal cell fate. Cell Metab. 25:661–672. 2017.PubMed/NCBI View Article : Google Scholar

25 

Stegen S, van Gastel N, Eelen G, Ghesquière B, D'Anna F, Thienpont B, Goveia J, Torrekens S, Van Looveren R, Luyten FP, et al: HIF-1α promotes glutamine-mediated redox homeostasis and glycogen-dependent bioenergetics to support postimplantation bone cell survival. Cell Metab. 23:265–279. 2016.PubMed/NCBI View Article : Google Scholar

26 

Liu S, Liu D, Chen C, Hamamura K, Moshaverinia A, Yang R, Liu Y, Jin Y and Shi S: MSC transplantation improves osteopenia via epigenetic regulation of notch signaling in lupus. Cell Metab. 22:606–618. 2015.PubMed/NCBI View Article : Google Scholar

27 

Mera P, Laue K, Ferron M, Confavreux C, Wei J, Galán-Díez M, Lacampagne A, Mitchell SJ, Mattison JA, Chen Y, et al: Osteocalcin signaling in myofibers is necessary and sufficient for optimum adaptation to exercise. Cell Metab. 23:1078–1092. 2016.PubMed/NCBI View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Wang C, Xie Q, Sun W, Zhou Y and Liu Y: lncRNA WT1‑AS is upregulated in osteoporosis and regulates the apoptosis of osteoblasts by interacting with p53. Exp Ther Med 22: 734, 2021.
APA
Wang, C., Xie, Q., Sun, W., Zhou, Y., & Liu, Y. (2021). lncRNA WT1‑AS is upregulated in osteoporosis and regulates the apoptosis of osteoblasts by interacting with p53. Experimental and Therapeutic Medicine, 22, 734. https://doi.org/10.3892/etm.2021.10166
MLA
Wang, C., Xie, Q., Sun, W., Zhou, Y., Liu, Y."lncRNA WT1‑AS is upregulated in osteoporosis and regulates the apoptosis of osteoblasts by interacting with p53". Experimental and Therapeutic Medicine 22.1 (2021): 734.
Chicago
Wang, C., Xie, Q., Sun, W., Zhou, Y., Liu, Y."lncRNA WT1‑AS is upregulated in osteoporosis and regulates the apoptosis of osteoblasts by interacting with p53". Experimental and Therapeutic Medicine 22, no. 1 (2021): 734. https://doi.org/10.3892/etm.2021.10166
Copy and paste a formatted citation
x
Spandidos Publications style
Wang C, Xie Q, Sun W, Zhou Y and Liu Y: lncRNA WT1‑AS is upregulated in osteoporosis and regulates the apoptosis of osteoblasts by interacting with p53. Exp Ther Med 22: 734, 2021.
APA
Wang, C., Xie, Q., Sun, W., Zhou, Y., & Liu, Y. (2021). lncRNA WT1‑AS is upregulated in osteoporosis and regulates the apoptosis of osteoblasts by interacting with p53. Experimental and Therapeutic Medicine, 22, 734. https://doi.org/10.3892/etm.2021.10166
MLA
Wang, C., Xie, Q., Sun, W., Zhou, Y., Liu, Y."lncRNA WT1‑AS is upregulated in osteoporosis and regulates the apoptosis of osteoblasts by interacting with p53". Experimental and Therapeutic Medicine 22.1 (2021): 734.
Chicago
Wang, C., Xie, Q., Sun, W., Zhou, Y., Liu, Y."lncRNA WT1‑AS is upregulated in osteoporosis and regulates the apoptosis of osteoblasts by interacting with p53". Experimental and Therapeutic Medicine 22, no. 1 (2021): 734. https://doi.org/10.3892/etm.2021.10166
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team